Abstract
Human papillomaviruses (HPVs) infect mucosal or cutaneous stratified epithelia. There are 5 genera and more than 200 types of HPV, each with a specific tropism and virulence. HPV infections are typically asymptomatic or result in benign tumors, which may be disseminated or persistent in rare cases, but a few oncogenic HPVs can cause cancers. This review deals with the human genetic and immunological basis of interindividual clinical variability in the course of HPV infections of the skin and mucosae. Typical epidermodysplasia verruciformis (EV) is characterized by β-HPV-driven flat wart-like and pityriasis-like cutaneous lesions and non-melanoma skin cancers in patients with inborn errors of EVER1-EVER2-CIB1-dependent skin-intrinsic immunity. Atypical EV is associated with other infectious diseases in patients with inborn errors of T cells. Severe cutaneous or anogenital warts, including anogenital cancers, are also driven by certain α-, γ-, μ or ν-HPVs in patients with inborn errors of T lymphocytes and antigen-presenting cells. The genetic basis of HPV diseases at other mucosal sites, such as oral multifocal epithelial hyperplasia or juvenile recurrent respiratory papillomatosis (JRRP), remains poorly understood. The human genetic dissection of HPV-driven lesions will clarify the molecular and cellular basis of protective immunity to HPVs, and should lead to novel diagnostic, preventive, and curative approaches in patients.
Similar content being viewed by others
References
Abd Hamid IJ, Slatter MA, McKendrick F et al (2017) Long-term outcome of hematopoietic stem cell transplantation for IL2RG/JAK3 SCID: a cohort report. Blood 129:2198–2201. https://doi.org/10.1182/blood-2016-11-748616
Abdollahpour H, Appaswamy G, Kotlarz D et al (2012) The phenotype of human STK4 deficiency. Blood 119:3450–3457. https://doi.org/10.1182/blood-2011-09-378158
Akoğlu G, Metin A, Ceylan GG et al (2015) Focal epithelial hyperplasia associated with human papillomavirus 13 and common human leukocyte antigen alleles in a Turkish family. Int J Dermatol 54:174–178. https://doi.org/10.1111/ijd.12538
Alazami AM, Al-Helale M, Alhissi S et al (2018) Novel CARMIL2 mutations in patients with variable clinical dermatitis, infections, and combined immunodeficiency. Front Immunol. https://doi.org/10.3389/fimmu.2018.00203
Almarza Novoa E, Kasbekar S, Thrasher AJ et al (2018) Leukocyte adhesion deficiency-I: a comprehensive review of all published cases. J Allergy Clin Immunol Pract 6:1418–1420.e10. https://doi.org/10.1016/j.jaip.2017.12.008
Al-Saud B, Alajlan H, Sabar H et al (2019) STK4 Deficiency in a patient with immune complex glomerulonephritis, salt-losing tubulopathy, and castleman’s-like disease. J Clin Immunol 39:823–826. https://doi.org/10.1007/s10875-019-00682-9
Angulo I, Vadas O, Garçon F et al (2013) Phosphoinositide 3-kinase δ gene mutation predisposes to respiratory infection and airway damage. Science 342:866–871. https://doi.org/10.1126/science.1243292
Antonsson A, Green AC, Mallitt K et al (2010) Prevalence and stability of antibodies to 37 human papillomavirus types —a population-based longitudinal study. Virology 407:26–32. https://doi.org/10.1016/j.virol.2010.07.046
Antony FC, Webster ADB, Bain MD, Harland CC (2002) Recalcitrant palmoplantar warts associated with adult-onset adenosine deaminase deficiency. Br J Dermatol 147:180–195. https://doi.org/10.1046/j.1365-2133.2002.47562.x
Arbyn M, Weiderpass E, Bruni L et al (2020) Estimates of incidence and mortality of cervical cancer in 2018: a worldwide analysis. Lancet Glob Health 8:e191–e203. https://doi.org/10.1016/S2214-109X(19)30482-6
Armstrong LR, Derkay CS, Reeves WC (1999) Initial results from the national registry for juvenile-onset recurrent respiratory papillomatosis. Arch Otolaryngol Neck Surg 125:743–748. https://doi.org/10.1001/archotol.125.7.743
Arts K, Bergerson JRE, Ombrello AK et al (2018) Warts and DADA2: a mere coincidence? J Clin Immunol 38:836–843. https://doi.org/10.1007/s10875-018-0565-0
Ashton R, Moledina J, Sivakumar B et al (2017) Considerations in surgical management of a Buschke-Lowenstein tumor in Netherton syndrome: a case report. Pediatr Dermatol 34:e328–e330. https://doi.org/10.1111/pde.13292
Asli B, Lantz O, DiSanto JP et al (2004) Roles of lymphoid cells in the differentiation of Langerhans dendritic cells in mice. Immunobiology 209:209–221. https://doi.org/10.1016/j.imbio.2004.05.002
Atschekzei F, Jacobs R, Wetzke M et al (2019) A novel CARMIL2 mutation resulting in combined immunodeficiency manifesting with dermatitis, fungal, and viral skin infections as well as selective antibody deficiency. J Clin Immunol 39:274–276. https://doi.org/10.1007/s10875-019-00628-1
Aydin SE, Kilic SS, Aytekin C et al (2015) DOCK8 Deficiency: clinical and immunological phenotype and treatment options—a review of 136 patients. J Clin Immunol 35:189–198. https://doi.org/10.1007/s10875-014-0126-0
Beilin C, Choudhuri K, Bouma G et al (2018) Dendritic cell-expressed common gamma-chain recruits IL-15 for trans-presentation at the murine immunological synapse. Wellcome Open Res. https://doi.org/10.12688/wellcomeopenres.14493.2
Betz SJ (2019) HPV-related papillary lesions of the oral mucosa: a review. Head Neck Pathol 13:80–90. https://doi.org/10.1007/s12105-019-01003-7
Bigley V, Haniffa M, Doulatov S et al (2011) The human syndrome of dendritic cell, monocyte, B and NK lymphoid deficiency. J Exp Med 208:227–234. https://doi.org/10.1084/jem.20101459
Bigley V, Barge D, Collin M (2016) Dendritic cell analysis in primary immunodeficiency. Curr Opin Allergy Clin Immunol 16:530–540. https://doi.org/10.1097/ACI.0000000000000322
Bigley V, Maisuria S, Cytlak U et al (2018) Biallelic interferon regulatory factor 8 mutation: a complex immunodeficiency syndrome with dendritic cell deficiency, monocytopenia, and immune dysregulation. J Allergy Clin Immunol 141:2234–2248. https://doi.org/10.1016/j.jaci.2017.08.044
Bitoun E, Chavanas S, Irvine AD et al (2002) Netherton syndrome: disease expression and spectrum of SPINK5 mutations in 21 families. J Invest Dermatol 118:352–361. https://doi.org/10.1046/j.1523-1747.2002.01603.x
Boerkoel CF, Takashima H, John J et al (2002) Mutant chromatin remodeling protein SMARCAL1 causes Schimke immuno-osseous dysplasia. Nat Genet 30:215–220. https://doi.org/10.1038/ng821
Boisson B, Puel A, Picard C, Casanova J-L (2017) Human IκBα gain of function: a severe and syndromic immunodeficiency. J Clin Immunol 37:397–412. https://doi.org/10.1007/s10875-017-0400-z
Bonagura VR, Hatam LJ, Rosenthal DW et al (2010) Recurrent respiratory Papillomatosis: a complex defect in immune responsiveness to human papillomavirus-6 and -11. APMIS Acta Pathol Microbiol Immunol Scand 118:455–470. https://doi.org/10.1111/j.1600-0463.2010.02617.x
Boshart M, Hausen zur H (1986) Human papillomaviruses in Buschke-Löwenstein tumors: physical state of the DNA and identification of a tandem duplication in the noncoding region of a human papillomavirus 6 subtype. J Virol 58:963–966
Bravo IG, Alonso Á (2004) Mucosal human papillomaviruses encode four different E5 proteins whose chemistry and phylogeny correlate with malignant or benign growth. J Virol 78:13613–13626. https://doi.org/10.1128/JVI.78.24.13613-13626.2004
Bredemeyer AL, Sharma GG, Huang C-Y et al (2006) ATM stabilizes DNA double-strand-break complexes during V(D)J recombination. Nature 442:466–470. https://doi.org/10.1038/nature04866
Brooks EG, Schmalstieg FC, Wirt DP et al (1990) A novel X-linked combined immunodeficiency disease. J Clin Invest 86:1623–1631
Casabonne D, Waterboer T, Michael KM et al (2009) The seroprevalence of human papillomavirus by immune status and by ethnicity in London. Infect Agent Cancer 4:14. https://doi.org/10.1186/1750-9378-4-14
Cattaneo F, Recher M, Masneri S et al (2013) Hypomorphic Janus kinase 3 mutations result in a spectrum of immune defects, including partial maternal T-cell engraftment. J Allergy Clin Immunol 131:1136–1145. https://doi.org/10.1016/j.jaci.2012.12.667
Chang MW, Romero R, Scholl PR, Paller AS (1998) Mucocutaneous manifestations of the hyper-IgM immunodeficiency syndrome. J Am Acad Dermatol 38:191–196. https://doi.org/10.1016/S0190-9622(98)70239-7
Chavanas S, Bodemer C, Rochat A et al (2000) Mutations in SPINK5, encoding a serine protease inhibitor, cause Netherton syndrome. Nat Genet 25:141–142. https://doi.org/10.1038/75977
Chinn IK, Sanders RP, Stray-Pedersen A et al (2017) Novel combined immune deficiency and radiation sensitivity blended phenotype in an adult with Biallelic variations in ZAP70 and RNF168. Front Immunol. https://doi.org/10.3389/fimmu.2017.00576
Chopra C, Davies G, Taylor M et al (2014) Immune deficiency in Ataxia-Telangiectasia: a longitudinal study of 44 patients. Clin Exp Immunol 176:275–282. https://doi.org/10.1111/cei.12262
Clewing JM, Fryssira H, Goodman D et al (2007) Schimke immunoosseous dysplasia: suggestions of genetic diversity. Hum Mutat 28:273–283. https://doi.org/10.1002/humu.20432
Clifford GM, Smith JS, Aguado T, Franceschi S (2003) Comparison of HPV type distribution in high-grade cervical lesions and cervical cancer: a meta-analysis. Br J Cancer 89:101–105. https://doi.org/10.1038/sj.bjc.6601024
Coleman N, Birley HD, Renton AM et al (1994) Immunological events in regressing genital warts. Am J Clin Pathol 102:768–774. https://doi.org/10.1093/ajcp/102.6.768
Collin MP, Hart DNJ, Jackson GH et al (2006) The fate of human Langerhans cells in hematopoietic stem cell transplantation. J Exp Med 203:27–33. https://doi.org/10.1084/jem.20051787
Collins M-K, Peters K, English JC et al (2018) Cutaneous squamous cell carcinoma with epidermodysplasia verruciformis-like features in a patient with Schimke immune-osseous dysplasia. J Cutan Pathol 45:465–467. https://doi.org/10.1111/cup.13139
Combes J-D, Pawlita M, Waterboer T et al (2014) Antibodies against high-risk human papillomavirus proteins as markers for invasive cervical cancer. Int J Cancer 135:2453–2461. https://doi.org/10.1002/ijc.28888
Cottineau J, Kottemann MC, Lach FP et al (2017) Inherited GINS1 deficiency underlies growth retardation along with neutropenia and NK cell deficiency. J Clin Invest 127:1991–2006. https://doi.org/10.1172/JCI90727
Coulter TI, Chandra A, Bacon CM et al (2017) Clinical spectrum and features of activated phosphoinositide 3-kinase δ syndrome: a large patient cohort study. J Allergy Clin Immunol 139:597–606.e4. https://doi.org/10.1016/j.jaci.2016.06.021
Crequer A, Picard C, Patin E et al (2012a) Inherited MST1 deficiency underlies susceptibility to EV-HPV infections. PLoS ONE 7:e44010. https://doi.org/10.1371/journal.pone.0044010
Crequer A, Troeger A, Patin E et al (2012b) Human RHOH deficiency causes T cell defects and susceptibility to EV-HPV infections. J Clin Invest 122:3239–3247. https://doi.org/10.1172/JCI62949
Crequer A, Picard C, Pedergnana V et al (2013) EVER2 deficiency is associated with mild T-cell abnormalities. J Clin Immunol 33:14–21. https://doi.org/10.1007/s10875-012-9749-1
Czernielewski JM, Demarchez M (1987) Further evidence for the self-reproducing capacity of Langerhans cells in human skin. J Invest Dermatol 88:17–20. https://doi.org/10.1111/1523-1747.ep12464659
D’Souza G, Carey TE, William WN et al (2014) Epidemiology of head and neck squamous cell cancer among hiv-infected patients. J Acquir Immune Defic Syndr 1999 65:603–610. https://doi.org/10.1097/QAI.0000000000000083
Da Silva DM, Movius CA, Raff AB et al (2014) Suppression of Langerhans cell activation is conserved amongst human papillomavirus α and β genotypes, but not a μ genotype. Virology. https://doi.org/10.1016/j.virol.2014.01.031
Dang TS, Willet JD, Griffin HR et al (2016) Defective Leukocyte Adhesion and Chemotaxis contributes to combined immunodeficiency in humans with autosomal recessive MST1 deficiency. J Clin Immunol 36:117–122. https://doi.org/10.1007/s10875-016-0232-2
de Jong SJ, Créquer A, Matos I et al (2018a) The human CIB1–EVER1–EVER2 complex governs keratinocyte-intrinsic immunity to β-papillomaviruses. J Exp Med 215:2289–2310. https://doi.org/10.1084/jem.20170308
de Jong SJ, Imahorn E, Itin P et al (2018b) Epidermodysplasia Verruciformis: inborn errors of immunity to human β-papillomaviruses. Front Microbiol. https://doi.org/10.3389/fmicb.2018.01222
de Villiers E-M, Fauquet C, Broker TR et al (2004) Classification of papillomaviruses. Virology 324:17–27. https://doi.org/10.1016/j.virol.2004.03.033
de la Calle-Martin O, Hernandez M, Ordi J et al (2001) Familial CD8 deficiency due to a mutation in the CD8α gene. J Clin Invest 108:117
Deckers J, Hammad H, Hoste E (2018) Langerhans cells: sensing the environment in health and disease. Front Immunol. https://doi.org/10.3389/fimmu.2018.00093
Derkay CS (1995) Task force on recurrent respiratory Papillomas: a preliminary report. Arch Otolaryngol Neck Surg 121:1386–1391. https://doi.org/10.1001/archotol.1995.01890120044008
Derkay CS, Wiatrak B (2008) Recurrent respiratory Papillomatosis: a review. The Laryngoscope 118:1236–1247. https://doi.org/10.1097/MLG.0b013e31816a7135
Dickinson RE, Milne P, Jardine L et al (2014) The evolution of cellular deficiency in GATA2 mutation. Blood 123:863–874. https://doi.org/10.1182/blood-2013-07-517151
Doorbar J, Egawa N, Griffin H et al (2015) Human papillomavirus molecular biology and disease association. Rev Med Virol 25:2–23. https://doi.org/10.1002/rmv.1822
Driessen GJ, Ijspeert H, Weemaes CMR et al (2013) Antibody deficiency in patients with ataxia telangiectasia is caused by disturbed B- and T-cell homeostasis and reduced immune repertoire diversity. J Allergy Clin Immunol 131:1367–1375.e9. https://doi.org/10.1016/j.jaci.2013.01.053
Drutman SB, Haerynck F, Zhong FL et al (2019) Homozygous NLRP1 gain-of-function mutation in siblings with a syndromic form of recurrent respiratory papillomatosis. Proc Natl Acad Sci 116:19055–19063. https://doi.org/10.1073/pnas.1906184116
Elkaim E, Neven B, Bruneau J et al (2016) Clinical and immunologic phenotype associated with activated phosphoinositide 3-kinase δ syndrome 2: a cohort study. J Allergy Clin Immunol 138:210–218.e9. https://doi.org/10.1016/j.jaci.2016.03.022
Emile JF, Geissmann F, Martin OC et al (2000) Langerhans cell deficiency in reticular dysgenesis. Blood 96:58–62
Etzioni A (2010) Defects in the leukocyte adhesion cascade. Clin Rev Allergy Immunol 38:54–60. https://doi.org/10.1007/s12016-009-8132-3
Fahey LM, Raff AB, Da Silva DM, Kast WM (2009) A major role for the minor capsid protein of human papillomavirus type 16 in immune escape. J Immunol Baltim Md 1950 183:6151–6156. https://doi.org/10.4049/jimmunol.0902145
Fernandes RA, Perez-Andres M, Blanco E et al (2019) Complete Multilineage CD4 expression defect associated with warts due to an inherited homozygous CD4 gene mutation. Front Immunol. https://doi.org/10.3389/fimmu.2019.02502
Filipe-Santos O, Bustamante J, Haverkamp MH et al (2006) X-linked susceptibility to mycobacteria is caused by mutations in NEMO impairing CD40-dependent IL-12 production. J Exp Med 203:1745–1759. https://doi.org/10.1084/jem.20060085
Fischer A, Notarangelo LD, Neven B et al (2015) Severe combined immunodeficiencies and related disorders. Nat Rev Dis Primer 1:15061. https://doi.org/10.1038/nrdp.2015.61
Fölster-Holst S, Stockfleth et al (1999) Comèl-Netherton syndrome complicated by papillomatous skin lesions containing human papillomaviruses 51 and 52 and plane warts containing human papillomavirus 16. Br J Dermatol 140:1139–1143. https://doi.org/10.1046/j.1365-2133.1999.02892.x
Frucht DM, Gadina M, Jagadeesh GJ et al (2001) Unexpected and variable phenotypes in a family with JAK3 deficiency. Genes Immun 2:422–432. https://doi.org/10.1038/sj.gene.6363802
Garcia-Corona C, Vega-Memije E, Mosqueda-Taylor A et al (2004) Association of HLA-DR4 (DRB1*0404) with human papillomavirus infection in patients with focal epithelial hyperplasia. Arch Dermatol 140:1227–1231. https://doi.org/10.1001/archderm.140.10.1227
Gaspar HB, Harwood C, Leigh I, Thrasher AJ (2004) Severe cutaneous papillomavirus disease after haematopoietic stem-cell transplantation in patients with severe combined immunodeficiency. Br J Haematol 127:232–233. https://doi.org/10.1111/j.1365-2141.2004.05176.x
Ghosh S, Bienemann K, Boztug K, Borkhardt A (2014) Interleukin-2-inducible T-cell kinase (ITK) deficiency—clinical and molecular aspects. J Clin Immunol 34:892–899. https://doi.org/10.1007/s10875-014-0110-8
Gineau L, Cognet C, Kara N et al (2012) Partial MCM4 deficiency in patients with growth retardation, adrenal insufficiency, and natural killer cell deficiency. J Clin Invest 122:821–832. https://doi.org/10.1172/JCI61014
Gissmann L, Villiers E-MD, Hausen HZ (1982) Analysis of human genital warts (condylomata acuminata) and other genital tumors for human papillomavirus type 6 DNA. Int J Cancer 29:143–146. https://doi.org/10.1002/ijc.2910290205
Glaichenhaus N, Shastri N, Littman DR, Turner JM (1991) Requirement for association of p56lck with CD4 in antigen-specific signal transduction in T cells. Cell 64:511–520. https://doi.org/10.1016/0092-8674(91)90235-Q
Gormley RH, Kovarik CL (2012) Human papillomavirus–related genital disease in the immunocompromised host: Part I. J Am Acad Dermatol 66:867.e1–867.e14. https://doi.org/10.1016/j.jaad.2010.12.050
Grandemange S, Sanchez E, Louis-Plence P et al (2017) A new autoinflammatory and autoimmune syndrome associated with NLRP1 mutations: NAIAD (NLRP1-associated autoinflammation with arthritis and dyskeratosis). Ann Rheum Dis 76:1191–1198. https://doi.org/10.1136/annrheumdis-2016-210021
Guirat-Dhouib N, Baccar Y, Mustapha IB et al (2012) Oral HPV infection and MHC class II deficiency (A study of two cases with atypical outcome). Clin Mol Allergy CMA 10:6. https://doi.org/10.1186/1476-7961-10-6
Gulino AV, Moratto D, Sozzani S et al (2004) Altered leukocyte response to CXCL12 in patients with warts hypogammaglobulinemia, infections, myelokathexis (WHIM) syndrome. Blood 104:444–452. https://doi.org/10.1182/blood-2003-10-3532
Haftek M, Jabłońska S, Szymańczyk J, Jarzabek-Chorzelska M (1987) Langerhans cells in epidermodysplasia verruciformis. Dermatologica 174:173–179. https://doi.org/10.1159/000249168
Halacli SO, Ayvaz DC, Sun-Tan C et al (2015) STK4 (MST1) deficiency in two siblings with autoimmune cytopenias: a novel mutation. Clin Immunol 161:316–323. https://doi.org/10.1016/j.clim.2015.06.010
Hall C, McCullough M, Angel C, Manton D (2010) Multifocal epithelial hyperplasia: a case report of a family of Somalian descent living in Australia. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 109:e20–e24. https://doi.org/10.1016/j.tripleo.2009.08.034
Hambleton S, Salem S, Bustamante J et al (2011) Mutations in IRF8 and human dendritic cell immunodeficiency. N Engl J Med 365:127–138. https://doi.org/10.1056/NEJMoa1100066
Hanalioglu D, Ayvaz DC, Ozgur TT et al (2017) A novel mutation in TAP1 gene leading to MHC class I deficiency: report of two cases and review of the literature. Clin Immunol 178:74–78. https://doi.org/10.1016/j.clim.2017.01.011
Hanna S, Etzioni A (2014) MHC class I and II deficiencies. J Allergy Clin Immunol 134:269–275. https://doi.org/10.1016/j.jaci.2014.06.001
Hanson EP, Monaco-Shawver L, Solt LA et al (2008) Hypomorphic NEMO mutation database and reconstitution system identifies phenotypic and immunologic diversity. J Allergy Clin Immunol 122:1169–1177.e16. https://doi.org/10.1016/j.jaci.2008.08.018
Harada Y, Tanaka Y, Terasawa M et al (2012) DOCK8 is a Cdc42 activator critical for interstitial dendritic cell migration during immune responses. Blood 119:4451–4461. https://doi.org/10.1182/blood-2012-01-407098
Hauck F, Randriamampita C, Martin E et al (2012) Primary T-cell immunodeficiency with immunodysregulation caused by autosomal recessive LCK deficiency. J Allergy Clin Immunol 130:1144–1152.e11. https://doi.org/10.1016/j.jaci.2012.07.029
Haverkamp MH, Marciano BE, Frucht DM et al (2014) Correlating interleukin-12 stimulated interferon-γ production and the absence of ectodermal dysplasia and anhidrosis (EDA) in patients with mutations in NF-κB essential modulator (NEMO). J Clin Immunol 34:436–443. https://doi.org/10.1007/s10875-014-9998-2
Henrickson SE, Treat JR (2017) Topical cidofovir for recalcitrant verrucae in individuals with severe combined immunodeficiency after hematopoietic stem cell transplantation. Pediatr Dermatol 34:e24–e25. https://doi.org/10.1111/pde.12992
Hessel H, Mittermüller J, Zitzelsberger H et al (1996) Combined immunophenotyping and FISH with sex chromosome-specific DNA probes for the detection of chimerism in epidermal Langerhans cells after sex-mismatched bone marrow transplantation. Histochem Cell Biol 106:481–485. https://doi.org/10.1007/BF02473310
Hibma MH (2012) The immune response to papillomavirus during infection persistence and regression. Open Virol J 6:241–248. https://doi.org/10.2174/1874357901206010241
Ho H-E, Byun M, Cunningham-Rundles C (2018) Disseminated cutaneous warts in X-linked hyper IgM syndrome. J Clin Immunol 38:454–456. https://doi.org/10.1007/s10875-018-0505-z
Horev L, Unger S, Molho-Pessach V et al (2015) Generalized verrucosis and HPV-3 susceptibility associated with CD4 T-cell lymphopenia caused by inherited human interleukin-7 deficiency. J Am Acad Dermatol 72:1082–1084. https://doi.org/10.1016/j.jaad.2015.02.1118
Hsu A, McReynolds L, Holland S (2015) GATA2 deficiency. Curr Opin Allergy Clin Immunol 15:104–109. https://doi.org/10.1097/ACI.0000000000000126
Iannacone MR, Gheit T, Waterboer T et al (2012) Case-control study of cutaneous human papillomaviruses in squamous cell carcinoma of the skin. Cancer Epidemiol Biomark Prev Publ Am Assoc Cancer Res Cosponsored Am Soc Prev Oncol 21:1303–1313. https://doi.org/10.1158/1055-9965.EPI-12-0032
Imahorn E, Yüksel Z, Spoerri I et al (2017) Novel TMC8 splice site mutation in epidermodysplasia verruciformis and review of HPV infections in patients with the disease. J Eur Acad Dermatol Venereol 31:1722–1726. https://doi.org/10.1111/jdv.14431
Iwatsuki K, Tagami H, Takigawa M, Yamada M (1986) Plane warts under spontaneous regression: immunopathologic study on cellular constituents leading to the inflammatory reaction. Arch Dermatol 122:655–659. https://doi.org/10.1001/archderm.1986.01660180061015
Jabłońska S, Orth G, Jarzabek-Chorzelska M et al (1979) Twenty-one years of follow-up studies of familial epidermodysplasia verruciformis. Dermatologica 158:309–327. https://doi.org/10.1159/000250775
Jablonska S, Orth G, Obalek S, Croissant O (1985) Cutaneous warts clinical, histologic, and virologic correlations. Clin Dermatol 3:71–82. https://doi.org/10.1016/0738-081X(85)90051-3
Kanitakis J, Petruzzo P, Dubernard J-M (2004) Turnover of epidermal Langerhans’ cells. N Engl J Med 351:2661–2662. https://doi.org/10.1056/NEJM200412163512523
Kawai T, Malech H (2009) WHIM syndrome: congenital immune deficiency disease. Curr Opin Hematol 16:20–26. https://doi.org/10.1097/MOH.0b013e32831ac557
Kilkenny M, Marks R (1996) The descriptive epidemiology of warts in the community. Australas J Dermatol 37:80–86. https://doi.org/10.1111/j.1440-0960.1996.tb01010.x
Kim JK, Yoon MS, Huh JY et al (2010) A novel mutation of the WAS gene in a patient with Wiskott-Aldrich syndrome presenting with recalcitrant viral warts. J Dermatol Sci 60:120–122. https://doi.org/10.1016/j.jdermsci.2010.08.007
Kitashima DY, Kobayashi T, Woodring T et al (2018) Langerhans cells prevent autoimmunity via expansion of keratinocyte antigen-specific regulatory T cells. EBioMedicine 27:293–303. https://doi.org/10.1016/j.ebiom.2017.12.022
Klein C, Lisowska-Grospierre B, LeDeist F et al (1993) Major histocompatibility complex class II deficiency: Clinical manifestations, immunologic features, and outcome. J Pediatr 123:921–928. https://doi.org/10.1016/S0022-3476(05)80388-9
Kobayashi K, Hisamatsu K, Suzui N et al (2018) A review of HPV-related head and neck cancer. J Clin Med. https://doi.org/10.3390/jcm7090241
Kosumi H, Natsuga K, Takashima S et al (2020) Two cases of interleukin-7–deficient generalized verrucosis. Clin Infect Dis. https://doi.org/10.1093/cid/ciz1240
Kraus M, Lev A, Simon AJ et al (2014) Disturbed B and T cell homeostasis and neogenesis in patients with ataxia telangiectasia. J Clin Immunol 34:561–572. https://doi.org/10.1007/s10875-014-0044-1
Kuriyama Y, Hattori M, Mitsui T et al (2018) Generalized verrucosis caused by various human papillomaviruses in a patient with GATA2 deficiency. J Dermatol 45:e108–e109. https://doi.org/10.1111/1346-8138.14149
Laffort C, Deist FL, Favre M et al (2004) Severe cutaneous papillomavirus disease after haemopoietic stem-cell transplantation in patients with severe combined immune deficiency caused by common γc cytokine receptor subunit or JAK-3 deficiency. The Lancet 363:2051–2054. https://doi.org/10.1016/S0140-6736(04)16457-X
Larregina A, Morelli A, Kolkowski E, Fainboim L (1996) Flow cytometric analysis of cytokine receptors on human Langerhans’ cells. Changes observed after short-term culture. Immunology 87:317–325. https://doi.org/10.1046/j.1365-2567.1996.451513.x
Larson DA, Derkay CS (2010) Epidemiology of recurrent respiratory papillomatosis. APMIS 118:450–454. https://doi.org/10.1111/j.1600-0463.2010.02619.x
Lazarczyk M, Pons C, Mendoza J-A et al (2008) Regulation of cellular zinc balance as a potential mechanism of EVER-mediated protection against pathogenesis by cutaneous oncogenic human papillomaviruses. J Exp Med 205:35–42. https://doi.org/10.1084/jem.20071311
Lazarczyk M, Dalard C, Hayder M et al (2012) EVER proteins, key elements of the natural anti-human papillomavirus barrier, are regulated upon T-cell activation. PLoS ONE 7:e39995. https://doi.org/10.1371/journal.pone.0039995
Leiding JW, Holland SM (2012) Warts and all: HPV in primary immunodeficiencies. J Allergy Clin Immunol 130:1030–1048. https://doi.org/10.1016/j.jaci.2012.07.049
Leong CM, Doorbar J, Nindl I et al (2010) Loss of epidermal Langerhans cells occurs in human papillomavirus α, γ, and μ but not β genus infections. J Invest Dermatol 130:472–480. https://doi.org/10.1038/jid.2009.266
Lévy A, Lebbe C (2006) Prise en charge des tumeurs de Buschke-Löwenstein. Ann Urol 40:175–178. https://doi.org/10.1016/j.anuro.2006.02.002
Lewandowsky F, Lutz W (1922) Ein Fall einer bisher nicht beschriebenen Hauterkrankung (Epidermodysplasia verruciformis). Arch Für Dermatol Syph 141:193–202
Li ALK, Walsh S, McKay DR (2011a) Surgical management of a giant condyloma of Buschke-Löwenstein in a patient with Netherton syndrome using the pedicled anterolateral thigh flap—a case report. J Plast Reconstr Aesthet Surg 64:1533–1536. https://doi.org/10.1016/j.bjps.2011.03.013
Li F-Y, Chaigne-Delalande B, Kanellopoulou C et al (2011b) Second messenger role for Mg 2+ revealed by human T-cell immunodeficiency. Nature 475:471–476. https://doi.org/10.1038/nature10246
Li S-L, Duo L-N, Wang H-J et al (2016) Identification of LCK mutation in a family with atypical epidermodysplasia verruciformis with T-cell defects and virus-induced squamous cell carcinoma. Br J Dermatol 175:1204–1209. https://doi.org/10.1111/bjd.14679
Lin J-X, Leonard WJ (2018) The common cytokine receptor γ chain family of cytokines. Cold Spring Harb Perspect Biol 10:a028449. https://doi.org/10.1101/cshperspect.a028449
Lin JH, Wang KY, Kraft S, Roberts RL (2009) Resolution of warts in association with subcutaneous immunoglobulin in immune deficiency. Pediatr Dermatol 26:155–158. https://doi.org/10.1111/j.1525-1470.2009.00874.x
Liu Y-Q, Zhang G-L, Mo X-H et al (2017) A novel homozygous DOCK8 mutation associated with unusual coexistence of gross molluscum contagiosum and epidermodysplasia verruciformis in a DOCK8 deficiency patient. J Eur Acad Dermatol Venereol 31:e504–e505. https://doi.org/10.1111/jdv.14344
Loenenbach AD, Poethko-Müller C, Pawlita M et al (2019) Mucosal and cutaneous Human Papillomavirus seroprevalence among adults in the prevaccine era in Germany—results from a nationwide population-based survey. Int J Infect Dis 83:3–11. https://doi.org/10.1016/j.ijid.2019.03.022
Maccari ME, Speckmann C, Heeg M et al (2019) Profound immunodeficiency with severe skin disease explained by concomitant novel CARMIL2 and PLEC1 loss-of-function mutations. Clin Immunol 208:108228. https://doi.org/10.1016/j.clim.2019.06.004
Magg T, Shcherbina A, Arslan D et al (2019) CARMIL2 deficiency presenting as very early onset inflammatory bowel disease. Inflamm Bowel Dis 25:1788–1795. https://doi.org/10.1093/ibd/izz103
Majewski S, Skopinska-Rożewska E, Jahłonska S et al (1986) Partial defects of cell-mediated immunity in patients with epidermodysplasia verruciformis. J Am Acad Dermatol 15:966–973. https://doi.org/10.1016/S0190-9622(86)70258-2
Mamaï O, Boussofara L, Denguezli M et al (2015) Multiple self-healing palmoplantar carcinoma: a familial predisposition to skin cancer with primary palmoplantar and conjunctival lesions. J Invest Dermatol 135:304–308. https://doi.org/10.1038/jid.2014.311
Marangi G, Garcovich S, Sante GD et al (2020) Complex muco-cutaneous manifestations of CARMIL2-associated combined immunodeficiency: a novel presentation of dysfunctional epithelial barriers. Acta Derm Venereol 100:adv00038. https://doi.org/10.2340/00015555-3370
Marrack P, Endres R, Shimonkevitz R et al (1983) The major histocompatibility complex-restricted antigen receptor on T cells. II. Role of the L3T4 product. J Exp Med 158:1077–1091. https://doi.org/10.1084/jem.158.4.1077
Marsico M, Mehta V, Chastek B et al (2014) Estimating the incidence and prevalence of juvenile-onset recurrent respiratory papillomatosis in publicly and privately insured claims databases in the United States. Sex Transm Dis 41:300–305. https://doi.org/10.1097/OLQ.0000000000000115
Martinon F, Burns K, Tschopp J (2002) The inflammasome: a molecular platform triggering activation of inflammatory caspases and processing of proIL-β. Mol Cell 10:417–426. https://doi.org/10.1016/S1097-2765(02)00599-3
Matthews K, Leong CM, Baxter L et al (2003) Depletion of langerhans cells in human papillomavirus type 16-infected skin is associated with E6-mediated down regulation of E-Cadherin. J Virol 77:8378–8385. https://doi.org/10.1128/JVI.77.15.8378-8385.2003
McDermott DH, Murphy PM (2019) WHIM syndrome: Immunopathogenesis, treatment and cure strategies. Immunol Rev 287:91–102. https://doi.org/10.1111/imr.12719
McDermott DH, Liu Q, Ulrick J et al (2011) The CXCR4 antagonist plerixafor corrects panleukopenia in patients with WHIM syndrome. Blood 118:4957–4962. https://doi.org/10.1182/blood-2011-07-368084
McDermott DH, Gao J-L, Liu Q et al (2015) Chromothriptic cure of WHIM syndrome. Cell 160:686–699. https://doi.org/10.1016/j.cell.2015.01.014
McDonnell PJ, McDonnell JM, Kessis T et al (1987) Detection of human papillomavirus type 6/11 DNA in conjunctival papillomas by in situ hybridization with radioactive probes. Hum Pathol 18:1115–1119. https://doi.org/10.1016/S0046-8177(87)80378-7
Mehta H, Paz JC, Sadikot RT (2008) Wiskott-Aldrich syndrome with bronchiectasis. Respir Med CME 1:54–58. https://doi.org/10.1016/j.rmedc.2007.10.004
Merad M, Hoffmann P, Ranheim E et al (2004) Depletion of host Langerhans cells before transplantation of donor alloreactive T cells prevents skin graft-versus-host disease. Nat Med 10:510–517. https://doi.org/10.1038/nm1038
Merad M, Ginhoux F, Collin M (2008) Origin, homeostasis and function of Langerhans cells and other langerin-expressing dendritic cells. Nat Rev Immunol 8:935–947. https://doi.org/10.1038/nri2455
Michael KM, Waterboer T, Sehr P et al (2008) Seroprevalence of 34 human papillomavirus types in the German general population. PLOS Pathog 4:e1000091. https://doi.org/10.1371/journal.ppat.1000091
Mitchell PS, Sandstrom A, Vance RE (2019) The NLRP1 inflammasome: new mechanistic insights and unresolved mysteries. Curr Opin Immunol 60:37–45. https://doi.org/10.1016/j.coi.2019.04.015
Moerman M, Danielides VG, Nousia C-S et al (2001) Recurrent focal epithelial hyperplasia due to HPV13 in an HIV-positive patient. Dermatology 203:339–341. https://doi.org/10.1159/000051786
Mohamadzadeh M, Ariizumi K, Sugamura K et al (1996) Expression of the common cytokine receptor γ chain by murine dendritic cells including epidermal Langerhans cells. Eur J Immunol 26:156–160. https://doi.org/10.1002/eji.1830260124
Mohamadzadeh M, Berard F, Essert G et al (2001) Interleukin 15 skews monocyte differentiation into dendritic cells with features of Langerhans cells. J Exp Med 194:1013–1020. https://doi.org/10.1084/jem.194.7.1013
Moshous D, Martin E, Carpentier W et al (2013) Whole-exome sequencing identifies Coronin-1A deficiency in 3 siblings with immunodeficiency and EBV-associated B-cell lymphoproliferation. J Allergy Clin Immunol 131:1594–1603.e9. https://doi.org/10.1016/j.jaci.2013.01.042
Nakayama Y, Asagoe K, Yamauchi A et al (2011) Dendritic cell subsets and immunological milieu in inflammatory human papilloma virus-related skin lesions. J Dermatol Sci 63:173–183. https://doi.org/10.1016/j.jdermsci.2011.05.006
Neven B, Leroy S, Decaluwe H et al (2009) Long-term outcome after hematopoietic stem cell transplantation of a single-center cohort of 90 patients with severe combined immunodeficiency. Blood 113:4114–4124. https://doi.org/10.1182/blood-2008-09-177923
Nicholls PK, Moore PF, Anderson DM et al (2001) Regression of canine oral papillomas is associated with infiltration of CD4+ and CD8+ Lymphocytes. Virology 283:31–39. https://doi.org/10.1006/viro.2000.0789
Nishio H, Matsui K, Tsuji H et al (2001) Immunolocalisation of the janus kinases (JAK)—signal transducers and activators of transcription (STAT) pathway in human epidermis. J Anat 198:581–589. https://doi.org/10.1046/j.1469-7580.2001.19850581.x
Noguchi M, Yi H, Rosenblatt HM et al (1993) Interleukin-2 receptor gamma chain mutation results in X-linked severe combined immunodeficiency in humans. Cell 73:147–157
Nonnenmacher M, Salmon J, Jacob Y et al (2006) Cottontail rabbit papillomavirus E8 protein is essential for wart formation and provides new insights into viral pathogenesis. J Virol 80:4890–4900. https://doi.org/10.1128/JVI.80.10.4890-4900.2006
Notarangelo LD, Hayward AR (2000) X-linked immunodeficiency with hyper-IgM (XHIM). Clin Exp Immunol 120:399–405. https://doi.org/10.1046/j.1365-2249.2000.01142.x
Nowak K, Linzner D, Thrasher AJ et al (2017) Absence of γ-chain in keratinocytes alters chemokine secretion, resulting in reduced immune cell recruitment. J Invest Dermatol 137:2120–2130. https://doi.org/10.1016/j.jid.2017.05.024
Nowak-Wegrzyn A, Crawford TO, Winkelstein JA et al (2004) Immunodeficiency and infections in ataxia-telangiectasia. J Pediatr 144:505–511. https://doi.org/10.1016/j.jpeds.2003.12.046
O’Driscoll M, Cerosaletti KM, Girard P-M et al (2001) DNA ligase IV mutations identified in patients exhibiting developmental delay and immunodeficiency. Mol Cell 8:1175–1185. https://doi.org/10.1016/S1097-2765(01)00408-7
Ochs HD, Filipovich AH, Veys P et al (2009) Wiskott-aldrich syndrome: diagnosis, clinical and laboratory manifestations, and treatment. Biol Blood Marrow Transplant 15:84–90. https://doi.org/10.1016/j.bbmt.2008.10.007
Okabayashi M, Angell MG, Christensen ND, Kreider JW (1991) Morphometric analysis and identification of infiltrating leucocytes in regressing and progressing shope rabbit papillomas. Int J Cancer 49:919–923. https://doi.org/10.1002/ijc.2910490620
Orange JS (2013) Natural killer cell deficiency. J Allergy Clin Immunol 132:515–525. https://doi.org/10.1016/j.jaci.2013.07.020
Ormerod AD, Finlay AY, Knight AG et al (1983) Immune deficiency and multiple viral warts: a possible variant of the Wiskott-Aldrich syndrome. Br J Dermatol 108:211–215. https://doi.org/10.1111/j.1365-2133.1983.tb00065.x
Orth G (1986) Epidermodysplasia verruciformis: a model for understanding the oncogenicity of human papillomaviruses. Ciba Found Symp 120:157–174. https://doi.org/10.1002/9780470513309.ch11
Orth G (2005) Human papillomaviruses associated with epidermodysplasia verruciformis in non-melanoma skin cancers: guilty or innocent? J Invest Dermatol. https://doi.org/10.1111/j.0022-202X.2005.23811.x
Orth G (2006) Genetics of epidermodysplasia verruciformis: Insights into host defense against papillomaviruses. Semin Immunol 18:362–374. https://doi.org/10.1016/j.smim.2006.07.008
Orth G (2008) Host defenses against human papillomaviruses: lessons from epidermodysplasia verruciformis. In: Beutler B (ed) Immunology, phenotype first: how mutations have established new principles and pathways in immunology. Springer, Berlin, pp 59–83
Otsuka M, Egawa G, Kabashima K (2018) Uncovering the mysteries of langerhans cells, inflammatory dendritic epidermal cells, and monocyte-derived langerhans cell-like cells in the epidermis. Front Immunol. https://doi.org/10.3389/fimmu.2018.01768
Ouederni M, Vincent QB, Frange P et al (2011) Major histocompatibility complex class II expression deficiency caused by a RFXANK founder mutation: a survey of 35 patients. Blood 118:5108–5118. https://doi.org/10.1182/blood-2011-05-352716
Patel H, Wagner M, Singhal P, Kothari S (2013) Systematic review of the incidence and prevalence of genital warts. BMC Infect Dis 13:39. https://doi.org/10.1186/1471-2334-13-39
Platt CD, Fried AJ, Hoyos-Bachiloglu R et al (2017) Combined immunodeficiency with EBV positive B cell lymphoma and epidermodysplasia verruciformis due to a novel homozygous mutation in RASGRP1. Clin Immunol Orlando Fla 183:142–144. https://doi.org/10.1016/j.clim.2017.08.007
Premoli-De-Percoco G, Cisternas JP, Ramírez JL, Galindo I (1993) Focal epithelial hyperplasia: human-papillomavirus-induced disease with a genetic predisposition in a Venezuelan family. Hum Genet 91:386–388. https://doi.org/10.1007/bf00217363
Puel A, Ziegler SF, Buckley RH, Leonard WJ (1998) Defective IL7R expression in T(−)B(+)NK(+) severe combined immunodeficiency. Nat Genet 20:394–397. https://doi.org/10.1038/3877
Punwani D, Pelz B, Yu J et al (2015) Coronin-1A: immune deficiency in humans and mice. J Clin Immunol 35:100–107. https://doi.org/10.1007/s10875-015-0130-z
Rahman S, Pierce Campbell CM, Waterboer T et al (2016) Seroprevalence of cutaneous human papillomaviruses (HPVs) among men in the multinational HPV Infection in Men study. J Gen Virol 97:3291–3301. https://doi.org/10.1099/jgv.0.000620
Ram S, Lewis LA, Rice PA (2010) Infections of people with complement deficiencies and patients who have undergone splenectomy. Clin Microbiol Rev 23:740–780. https://doi.org/10.1128/CMR.00048-09
Ramoz N, Rueda L-A, Bouadjar B et al (2002) Mutations in two adjacent novel genes are associated with epidermodysplasia verruciformis. Nat Genet 32:579–581. https://doi.org/10.1038/ng1044
Ravell JC, Matsuda-Lennikov M, Chauvin SD et al (2020) Defective glycosylation and multisystem abnormalities characterize the primary immunodeficiency XMEN disease. J Clin Invest 130:507–522. https://doi.org/10.1172/JCI131116
Reith W, Mach B (2001) The bare lymphocyte syndrome and the regulation of MHC expression. Annu Rev Immunol 19:331–373. https://doi.org/10.1146/annurev.immunol.19.1.331
Renner ED, Hartl D, Rylaarsdam S et al (2009) Comèl-Netherton syndrome—defined as primary immunodeficiency. J Allergy Clin Immunol 124:536–543. https://doi.org/10.1016/j.jaci.2009.06.009
Rivas-Caicedo A, Soldevila G, Fortoul TI et al (2009) Jak3 is involved in dendritic cell maturation and CCR7-dependent migration. PLoS ONE. https://doi.org/10.1371/journal.pone.0007066
Rosenzweig SD, Holland SM (2004) Phagocyte immunodeficiencies and their infections. J Allergy Clin Immunol 113:620–626. https://doi.org/10.1016/j.jaci.2004.02.001
Rothblum-Oviatt C, Wright J, Lefton-Greif MA et al (2016) Ataxia telangiectasia: a review. Orphanet J Rare Dis 11:159. https://doi.org/10.1186/s13023-016-0543-7
Said AK, Leao JC, Fedele S, Porter SR (2013) Focal epithelial hyperplasia—an update. J Oral Pathol Med 42:435–442. https://doi.org/10.1111/jop.12009
Salzer E, Cagdas D, Hons M et al (2016) RASGRP1 deficiency causes immunodeficiency with impaired cytoskeletal dynamics. Nat Immunol 17:1352–1360. https://doi.org/10.1038/ni.3575
Sanal O, Jing H, Ozgur T et al (2012) Additional diverse findings expand the clinical presentation of DOCK8 deficiency. J Clin Immunol 32:698–708. https://doi.org/10.1007/s10875-012-9664-5
Schepp J, Chou J, Skrabl-Baumgartner A et al (2017) 14 years after discovery: clinical follow-up on 15 patients with inducible co-stimulator deficiency. Front Immunol. https://doi.org/10.3389/fimmu.2017.00964
Schiffman M, Doorbar J, Wentzensen N et al (2016) Carcinogenic human papillomavirus infection. Nat Rev Dis Primer 2:16086. https://doi.org/10.1038/nrdp.2016.86
Schiller JT, Castellsagué X, Garland SM (2012) A review of clinical trials of human papillomavirus prophylactic vaccines. Vaccine 30:F123–F138. https://doi.org/10.1016/j.vaccine.2012.04.108
Schipp C, Schlütermann D, Hönscheid A et al (2018) EBV negative lymphoma and autoimmune lymphoproliferative syndrome like phenotype extend the clinical spectrum of primary immunodeficiency caused by STK4 deficiency. Front Immunol. https://doi.org/10.3389/fimmu.2018.02400
Schmalstieg FC, Leonard WJ, Noguchi M et al (1995) Missense mutation in exon 7 of the common gamma chain gene causes a moderate form of X-linked combined immunodeficiency. J Clin Invest 95:1169–1173
Schober T, Magg T, Laschinger M et al (2017) A human immunodeficiency syndrome caused by mutations in CARMIL2. Nat Commun 8:14209. https://doi.org/10.1038/ncomms14209
Selvakumar R, Schmitt A, Iftner T et al (1997) Regression of papillomas induced by cottontail rabbit papillomavirus is associated with infiltration of CD8+ cells and persistence of viral DNA after regression. J Virol 71:5540–5548
Sharafian S, Ziaee V, Shahrooei M et al (2019) A novel STK4 mutation presenting with juvenile idiopathic arthritis and epidermodysplasia verruciformis. J Clin Immunol 39:11–14. https://doi.org/10.1007/s10875-018-0586-8
Shovlin CL, Hughes JMB, Simmonds HA et al (1993) Adult presentation of adenosine deaminase deficiency. The Lancet 341:1471. https://doi.org/10.1016/0140-6736(93)90910-9
Sjö NC, von Buchwald C, Cassonnet P et al (2007) Human papillomavirus in normal conjunctival tissue and in conjunctival papilloma: types and frequencies in a large series. Br J Ophthalmol 91:1014–1015. https://doi.org/10.1136/bjo.2006.108811
Sogkas G, Adriawan IR, Ringshausen FC et al (2020) A novel NFKBIA variant substituting serine 36 of IκBα causes immunodeficiency with warts, bronchiectasis and juvenile rheumatoid arthritis in the absence of ectodermal dysplasia. Clin Immunol 210:108269. https://doi.org/10.1016/j.clim.2019.108269
Sorte HS, Osnes LT, Fevang B et al (2016) A potential founder variant in CARMIL2/RLTPR in three Norwegian families with warts, molluscum contagiosum, and T-cell dysfunction. Mol Genet Genomic Med 4:604. https://doi.org/10.1002/mgg3.237
Spinner MA, Sanchez LA, Hsu AP et al (2014) GATA2 deficiency: a protean disorder of hematopoiesis, lymphatics, and immunity. Blood 123:809–821. https://doi.org/10.1182/blood-2013-07-515528
Staples ER, McDermott EM, Reiman A et al (2008) Immunodeficiency in ataxia telangiectasia is correlated strongly with the presence of two null mutations in the ataxia telangiectasia mutated gene. Clin Exp Immunol 153:214–220. https://doi.org/10.1111/j.1365-2249.2008.03684.x
Stepensky P, Rensing-Ehl A, Gather R et al (2015) Early-onset Evans syndrome, immunodeficiency, and premature immunosenescence associated with tripeptidyl-peptidase II deficiency. Blood 125:753–761. https://doi.org/10.1182/blood-2014-08-593202
Stevens DA, Ferrington RA, Merigan TC, Marinkovich VA (1975) Randomized trial of transfer factor treatment of human warts. Clin Exp Immunol 21:520–524
Stray-Pedersen A, Jouanguy E, Crequer A et al (2014) Compound heterozygous CORO1A mutations in siblings with a mucocutaneous-immunodeficiency syndrome of epidermodysplasia verruciformis-HPV, molluscum contagiosum and granulomatous tuberculoid leprosy. J Clin Immunol 34:871–890. https://doi.org/10.1007/s10875-014-0074-8
Strong J, Wang Q, Killeen N (2001) Impaired survival of T helper cells in the absence of CD4. Proc Natl Acad Sci 98:2566–2571. https://doi.org/10.1073/pnas.051329698
Sullivan KE, Mullen CA, Blaese RM, Winkelstein JA (1994) A multiinstitutional survey of the Wiskott-Aldrich syndrome. J Pediatr 125:876–885. https://doi.org/10.1016/S0022-3476(05)82002-5
Tahiat A, Badran YR, Chou J et al (2017) Epidermodysplasia verruciformis as a manifestation of ARTEMIS deficiency in a young adult. J Allergy Clin Immunol 139:372–375.e4. https://doi.org/10.1016/j.jaci.2016.07.024
Tamura S, Higuchi K, Tamaki M et al (2015) Novel compound heterozygous DNA ligase IV mutations in an adolescent with a slowly-progressing radiosensitive-severe combined immunodeficiency. Clin Immunol 160:255–260. https://doi.org/10.1016/j.clim.2015.07.004
Tarzi MD, Jenner M, Hattotuwa K et al (2005) Sporadic case of warts, hypogammaglobulinemia, immunodeficiency, and myelokathexis syndrome. J Allergy Clin Immunol 116:1101–1105. https://doi.org/10.1016/j.jaci.2005.08.040
Tassone L, Moratto D, Vermi W et al (2010) Defect of plasmacytoid dendritic cells in warts, hypogammaglobulinemia, infections, myelokathexis (WHIM) syndrome patients. Blood 116:4870–4873. https://doi.org/10.1182/blood-2010-03-272096
Theotoka D, Morkin MI, Galor A, Karp CL (2019) Update on diagnosis and management of conjunctival Papilloma. Eye Vis 6:18. https://doi.org/10.1186/s40662-019-0142-5
Tobin E, Rohwedder A, Holland SM et al (2003) Recurrent ‘sterile’ verrucous cyst abscesses and epidermodysplasia verruciformis-like eruption associated with idiopathic CD4 lymphopenia. Br J Dermatol 149:627–633. https://doi.org/10.1046/j.1365-2133.2003.05543.x
Toboni MD, Bevis KS (2018) Vulvar cancer as a result of GATA2 deficiency, a rare genetic immunodeficiency syndrome. Obstet Gynecol 132:1112–1115. https://doi.org/10.1097/AOG.0000000000002905
Trotta L, Martelius T, Siitonen T et al (2018) ADA2 deficiency: clonal lymphoproliferation in a subset of patients. J Allergy Clin Immunol 141:1534–1537.e8. https://doi.org/10.1016/j.jaci.2018.01.012
Tschachler E, Bergstresser PR, Stingl G (1996) HIV-related skin diseases. The Lancet 348:659–663. https://doi.org/10.1016/S0140-6736(96)01032-X
Uhlén M, Fagerberg L, Hallström BM et al (2015) Tissue-based map of the human proteome. Science. https://doi.org/10.1126/science.1260419
Vahidnezhad H, Youssefian L, Saeidian AH et al (2019) A CIB1 splice-site founder mutation in families with typical epidermodysplasia verruciformis. J Invest Dermatol 139:1195–1198. https://doi.org/10.1016/j.jid.2018.11.011
van de Vijver E, Maddalena A, Sanal Ö et al (2012) Hematologically important mutations: leukocyte adhesion deficiency (first update). Blood Cells Mol Dis 48:53–61. https://doi.org/10.1016/j.bcmd.2011.10.004
Van Doorslaer K, Tan Q, Xirasagar S et al (2013) The Papillomavirus Episteme: a central resource for papillomavirus sequence data and analysis. Nucleic Acids Res 41:D571–D578. https://doi.org/10.1093/nar/gks984
Van Doorslaer K, Li Z, Xirasagar S et al (2017) The Papillomavirus Episteme: a major update to the papillomavirus sequence database. Nucleic Acids Res 45:D499–D506. https://doi.org/10.1093/nar/gkw879
van Voorst Vader PC, de Jong MC, Blanken R et al (1987) Epidermodysplasia verruciformis: langerhans cells, immunologic effect of retinoid treatment and cytogenetics. Arch Dermatol Res 279:366–373. https://doi.org/10.1007/bf00412621
Venkatesan NN, Pine HS, Underbrink MP (2012) Recurrent respiratory papillomatosis. Otolaryngol Clin North Am 45:671–ix. https://doi.org/10.1016/j.otc.2012.03.006
Volk T, Pannicke U, Reisli I et al (2015) DCLRE1C (ARTEMIS) mutations causing phenotypes ranging from atypical severe combined immunodeficiency to mere antibody deficiency. Hum Mol Genet 24:7361–7372. https://doi.org/10.1093/hmg/ddv437
Wang H, Kadlecek TA, Au-Yeung BB et al (2010) ZAP-70: an essential kinase in T-cell signaling. Cold Spring Harb Perspect Biol. https://doi.org/10.1101/cshperspect.a002279
Wang Y, Ma CS, Ling Y et al (2016) Dual T cell– and B cell–intrinsic deficiency in humans with biallelic RLTPR mutations. J Exp Med 213:2413–2435. https://doi.org/10.1084/jem.20160576
Waterboer T, Neale R, Michael KM et al (2009) Antibody responses to 26 skin human papillomavirus types in the Netherlands, Italy and Australia. J Gen Virol 90:1986–1998. https://doi.org/10.1099/vir.0.010637-0
Weber F, Fuchs PG, Pfister HJ et al (2001) Human papillomavirus infection in Netherton’s syndrome. Br J Dermatol 144:1044–1049. https://doi.org/10.1046/j.1365-2133.2001.04196.x
West HC, Bennett CL (2018) Redefining the role of langerhans cells as immune regulators within the skin. Front Immunol. https://doi.org/10.3389/fimmu.2017.01941
West ES, Kingsbery MY, Mintz EM et al (2014) Generalized verrucosis in a patient with GATA2 deficiency. Br J Dermatol 170:1182–1186. https://doi.org/10.1111/bjd.12794
Wieland U, Kreuter A, Pfister H (2014) Human papillomavirus and immunosuppression. Curr Probl Dermatol 45:154–165. https://doi.org/10.1159/000357907
Winkelstein JA, Marino MC, Lederman HM et al (2006) X-linked agammaglobulinemia: report on a United States registry of 201 patients. Medicine (Baltimore) 85:193–202. https://doi.org/10.1097/01.md.0000229482.27398.ad
Winter S, Martin E, Boutboul D et al (2018) Loss of RASGRP1 in humans impairs T-cell expansion leading to Epstein-Barr virus susceptibility. EMBO Mol Med 10:188–199. https://doi.org/10.15252/emmm.201708292
Woodbine L, Grigoriadou S, Goodarzi AA et al (2010) An Artemis polymorphic variant reduces Artemis activity and confers cellular radiosensitivity. DNA Repair 9:1003–1010. https://doi.org/10.1016/j.dnarep.2010.07.001
Woodham AW, Yan L, Skeate JG et al (2016) T cell ignorance is bliss: T cells are not tolerized by Langerhans cells presenting human papillomavirus antigens in the absence of costimulation. Papillomavirus Res Amst Neth 2:21–30. https://doi.org/10.1016/j.pvr.2016.01.002
Yamashita M, Wakatsuki R, Kato T et al (2019) A synonymous splice site mutation in IL2RG gene causes late-onset combined immunodeficiency. Int J Hematol 109:603–611. https://doi.org/10.1007/s12185-019-02619-9
Yee CS, Massaad MJ, Bainter W et al (2016) Recurrent viral infections associated with a homozygous CORO1A mutation that disrupts oligomerization and cytoskeletal association. J Allergy Clin Immunol 137:879–888.e2. https://doi.org/10.1016/j.jaci.2015.08.020
Yilmaz GG, Yilmaz E, Coşkun M et al (1995) Cutaneous histoplasmosis in a child with hyper-IgM. Pediatr Dermatol 12:235–238. https://doi.org/10.1111/j.1525-1470.1995.tb00166.x
Youssefian L, Vahidnezhad H, Yousefi M et al (2019) Inherited interleukin 2–inducible T-cell (ITK) kinase deficiency in siblings with epidermodysplasia verruciformis and hodgkin lymphoma. Clin Infect Dis 68:1938–1941. https://doi.org/10.1093/cid/ciy942
Zhang Q, Dove CG, Hor JL et al (2014) DOCK8 regulates lymphocyte shape integrity for skin antiviral immunity. J Exp Med 211:2549–2566. https://doi.org/10.1084/jem.20141307
Zhang Q, Boisson B, Béziat V et al (2018) Human hyper-IgE syndrome: singular or plural? Mamm Genome 29:603–617. https://doi.org/10.1007/s00335-018-9767-2
Zhong FL, Mamaï O, Sborgi L et al (2016) Germline NLRP1 mutations cause skin inflammatory and cancer susceptibility syndromes via inflammasome activation. Cell 167:187–202.e17. https://doi.org/10.1016/j.cell.2016.09.001
Zimmer J, Andres E, Donato L et al (2005) Clinical and immunological aspects of HLA class I deficiency. QJM Mon J Assoc Physicians 98:719–27. https://doi.org/10.1093/qjmed/hci112
Acknowledgements
I would like to thank Jean-Laurent Casanova and Emmanuelle Jouanguy for their critical review of this manuscript and helpful suggestions. I would also like to thank the members of the Human Genetics of Infectious Diseases Laboratory for helpful discussions.
This work was funded, in part, by the National Center for Advancing Translational Sciences (NCATS), National Institutes of Health (NIH) Clinical and Translational Science Award (CTSA) program (UL1TR001866), NIH (R21AI107508, R01AI143810), the French National Research Agency (ANR) under the ‘Investments for the future’ program (ANR-10-IAHU-01), Integrative Biology of Emerging Infectious Diseases Laboratoire d’Excellence (ANR-10-LABX-62-IBEID), the French Foundation for Medical Research (FRM) (EQU201903007798), the Rockefeller University, Institut National de la Santé et de la Recherche Médicale (INSERM), the Howard Hughes Medical Institute, Paris University, and the St. Giles Foundation.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The author has no conflict of interest to declare.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Béziat, V. Human genetic dissection of papillomavirus-driven diseases: new insight into their pathogenesis. Hum Genet 139, 919–939 (2020). https://doi.org/10.1007/s00439-020-02183-x
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00439-020-02183-x